Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) Declares $0.02 Dividend

Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) announced a dividend on Tuesday, December 17th,investing.com reports. Stockholders of record on Friday, December 20th will be given a dividend of 0.019 per share by the biotechnology company on Wednesday, December 18th. This represents a dividend yield of 117.8%. The ex-dividend date is Thursday, December 19th.

Bellerophon Therapeutics Stock Performance

NASDAQ BLPH opened at $0.02 on Tuesday. The company has a market capitalization of $196,951.30, a PE ratio of -0.02 and a beta of 0.74. The company has a 50-day simple moving average of $0.04 and a 200 day simple moving average of $0.04. Bellerophon Therapeutics has a 52-week low of $0.01 and a 52-week high of $0.02.

Analyst Upgrades and Downgrades

Separately, StockNews.com started coverage on shares of Bellerophon Therapeutics in a report on Tuesday, December 10th. They issued a “hold” rating for the company.

About Bellerophon Therapeutics

Bellerophon Therapeutics, Inc, a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its primary product is INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension.